Toronto Innovation Acceleration Partners

Founded in 2017, Phenomic AI is a Toronto-based company that develops artificial intelligence-driven drug discovery platforms. Its technology analyzes phenotypes in complex disease models like high-content co-culture and 3D assays, enabling pharmaceutical companies to discover drugs more efficiently.

Phycus Biotechnologies specializes in biotechnology solutions. It develops products from biological sources, primarily algae and aquatic organisms, to create bioactive compounds used in cosmetics, dietary supplements, functional foods, and natural pesticides.

Notch Therapeutics is a Toronto-based company developing immune cell therapies using induced pluripotent stem cell technology to create gene-edited allogeneic T cells. Its platform enables precise control of Notch signaling during T-cell development, enabling scalable manufacture of a uniform supply of therapeutic T cells for cancer indications such as non-Hodgkin lymphoma, leukemia, and multiple myeloma. The approach aims to overcome bottlenecks in cell therapy development by integrating advanced product design with commercially compatible processes, supporting a next-generation pipeline of cell therapies.

Appulse Power Inc. is a Toronto-based company that specializes in the design and manufacture of application-specific integrated circuits (ASIC) focused on semiconductor technology. Founded in 2015, the company has developed innovative power management solutions aimed at enhancing AC/DC power conversion efficiency. Appulse Power's products are designed to be lightweight and compact, addressing the growing demand for smaller and more integrated electronic devices while reducing power losses. Their technology consolidates multiple electronic device chargers into a single unit, making it particularly relevant for the Internet of Things and smart energy markets. By pushing the boundaries of traditional power conversion technology, Appulse Power aims to deliver higher efficiency and lower costs compared to existing solutions.

Zucara Therapeutics Inc. is a biotechnology company focused on developing innovative therapeutics to prevent hypoglycemia, or low blood sugar, in patients with diabetes. Established in 2014 and headquartered in Toronto, Canada, with an additional office in Vancouver, Zucara is pioneering a once-daily treatment that aims to regulate the hormone somatostatin in the pancreas. This treatment specifically targets somatostatin type 2 receptors, which are not effectively controlled in patients with Type 1 diabetes. Zucara's approach presents a significant advancement in diabetes care by functioning as a preventative measure against hypoglycemia, contrasting with existing therapies that only provide rescue during acute episodes. Through its pre-clinical technology, Zucara Therapeutics aims to restore natural glucose levels in the blood, ultimately enhancing the quality of life for individuals living with diabetes.

Appulse Power Inc. is a Toronto-based company that specializes in the design and manufacture of application-specific integrated circuits (ASIC) focused on semiconductor technology. Founded in 2015, the company has developed innovative power management solutions aimed at enhancing AC/DC power conversion efficiency. Appulse Power's products are designed to be lightweight and compact, addressing the growing demand for smaller and more integrated electronic devices while reducing power losses. Their technology consolidates multiple electronic device chargers into a single unit, making it particularly relevant for the Internet of Things and smart energy markets. By pushing the boundaries of traditional power conversion technology, Appulse Power aims to deliver higher efficiency and lower costs compared to existing solutions.

QD Solar Inc., founded in 2014 and based in Toronto, Canada, is a company that develops advanced photovoltaic cells using colloidal quantum dot technology. The company's innovative approach combines efficient silicon solar cells with infrared solar cells in a hybrid architecture to capture more of the solar spectrum than traditional silicon cells alone. This technology aims to enhance the performance of solar cells, making them more cost-effective and efficient. QD Solar was spun off from the University of Toronto and focuses on creating new nanomaterial semiconductors to promote sustainable development and increase the use of renewable energy sources.

Fibrocor Therapeutics L.P. is a biotechnology company based in Toronto, Canada, established in 2017. The company specializes in developing tissue-specific therapeutics aimed at treating the underlying causes of fibrotic diseases affecting the kidneys and other organs. Fibrocor focuses on disease-modifying therapeutics for fibrosis and has identified a lead program for which it collaborates with Evotec to develop novel molecules. Utilizing patient-derived tissue samples, Fibrocor's innovative platform uncovers critical pathways in the fibrogenic process, facilitating the identification of new disease targets and the development of a comprehensive pipeline of therapeutics.

LegUp Computing Inc., founded in 2015 by Dr. Andrew Canis, Dr. Jongsok Choi, Ruolong Lian, and Professor Jason Anderson, develops a cloud platform that facilitates programming, deployment, scaling, and management of field-programmable gate array (FPGA) devices for accelerating high-performance applications such as low-latency database processing and machine learning workloads. Originally developed at the University of Toronto, LegUp's platform offers a novel programming model enabling threaded C/C++ software to target FPGAs connected to high-bandwidth networks efficiently. As of October 9, 2020, LegUp operates as a subsidiary of Microchip Technology Incorporated, headquartered in Toronto, Canada.

Zucara Therapeutics Inc. is a biotechnology company focused on developing innovative therapeutics to prevent hypoglycemia, or low blood sugar, in patients with diabetes. Established in 2014 and headquartered in Toronto, Canada, with an additional office in Vancouver, Zucara is pioneering a once-daily treatment that aims to regulate the hormone somatostatin in the pancreas. This treatment specifically targets somatostatin type 2 receptors, which are not effectively controlled in patients with Type 1 diabetes. Zucara's approach presents a significant advancement in diabetes care by functioning as a preventative measure against hypoglycemia, contrasting with existing therapies that only provide rescue during acute episodes. Through its pre-clinical technology, Zucara Therapeutics aims to restore natural glucose levels in the blood, ultimately enhancing the quality of life for individuals living with diabetes.

BlueDot is a global health intelligence company that empowers organizations to anticipate and respond effectively to infectious disease threats. Using AI-driven analytics and human expertise, it monitors over 190 diseases worldwide, providing critical insights on outbreaks.

Founded in Toronto, Canada in 2012, Crowdmark is an education technology company that offers a Web-based application for streamlined document assessment. It uses AI to administer and grade online assessments, serving students, teachers, and educational institutions worldwide.

Treata Smart Solutions specializes in caregiving technology aimed at assisting memory-impaired adults. Founded in 2012 and headquartered in Toronto, Ontario, the company offers three main products: The Smart Lost Item Finder, The Smart Wandering Assistant, and The Smart Reminder. These devices leverage existing smartphone technology, incorporating patent-pending hardware and software to enhance their functionality. The company's emergency response system is particularly valuable for caregivers, as it provides real-time location updates and alerts via a connected smartphone app, ensuring that caregivers are informed about the whereabouts and safety of their loved ones.

Founded in Toronto, Canada in 2012, Crowdmark is an education technology company that offers a Web-based application for streamlined document assessment. It uses AI to administer and grade online assessments, serving students, teachers, and educational institutions worldwide.